MICROMASS UK LTD

Their core work

Micromass UK Ltd, operating under Waters Corporation, is a major manufacturer of mass spectrometry instruments based in the UK. In H2020, they contributed specialized analytical instrumentation and mass spectrometry expertise to research training networks, enabling early-stage researchers to access advanced ion mobility and chemical ionization techniques. Their role is that of an industry partner providing equipment access, technical training, and application know-how to academic consortia studying biomolecular analysis and analytical chemistry methods.

What they specialise in

How they've shifted over time

Early H2020 participation (2015-2019) centred on fundamental mass spectrometry methods — protein-lipid adduct analysis in MASSTRPLAN and ion-molecule reaction chemistry in IMPACT, both training-network projects. The more recent HS-SEQ project (2020-2025) shifts toward biomedical applications, combining ion mobility MS with heparin sequencing and therapeutic strategies for Parkinson's disease. This reflects a clear move from method development toward translational, health-oriented analytical challenges.

Moving from foundational mass spectrometry instrumentation toward disease-relevant biomolecular analysis, suggesting growing interest in health and pharmaceutical collaborations.

How they like to work

Micromass/Waters exclusively participates as a partner or third party — never as a coordinator — consistent with a large instrument company providing infrastructure and expertise rather than leading academic research agendas. Despite only three projects, they have worked with 53 partners across 15 countries, a consequence of joining large MSCA training networks with broad European membership. This makes them an accessible industry partner accustomed to multi-institutional, multinational consortia.

Through three large training networks, Micromass has collaborated with 53 unique partners across 15 countries, giving them broad European reach despite a small project count. Their network spans analytical chemistry and biomedical research communities.

What sets them apart

As a subsidiary of Waters Corporation — one of the world's leading mass spectrometry manufacturers — Micromass brings direct access to commercial-grade analytical instruments that most academic partners cannot provide independently. Their value in a consortium is straightforward: they supply the hardware, application expertise, and industry training placements that make research training networks credible and practical. For any project needing advanced MS capabilities, they are one of very few instrument manufacturers actively engaged in EU research networks.

Highlights from their portfolio

• HS-SEQ
  Their only funded project (EUR 12,500), combining mass spectrometry with heparin sequencing for Parkinson's disease therapeutic strategies — a clear translational health application.
• IMPACT
  Focused specifically on ion-molecule analytical chemistry technologies, directly aligned with Micromass's core instrumentation business in chemical ionization MS.